期刊文献+

磷脂酰肌醇蛋白多糖-1与趋化因子受体CXCR7在胰腺癌中的表达及临床意义 被引量:2

Expression and clinical significance of glypican-1 and CXCR7 in pancreatic carcinoma
原文传递
导出
摘要 目的 探讨磷脂酰肌醇蛋白多糖-1(glypicans-1,GPC-1)与趋化因子受体CXCR7在胰腺癌中的表达及临床意义.方法 应用免疫组织化学方法检测52例胰腺癌组织及30例正常胰腺组织中GPC-1与CXCR7的表达及相关性,电话随访统计预后情况.结果 胰腺癌组织中GPC-1和CXCR7阳性表达率(56.79%、51.92%)均明显高于正常胰腺组织(x2=27.293、23.224,P均<0.05),且二者的表达相互之间呈正相关性(r=0.758,P<0.001),同时GPC-1和CXCR7的阳性表达与淋巴结是否转移相关(x2=14.470、14.034,P<0.05).GPC-1与CXCR7的阳性表达与患者术后生存时间均无统计学意义(Log Rank =0.086、0.006,P均<0.05).结论 GPC-1和CXCR7与胰腺癌的发生发展关系密切,且与其侵袭转移相关.二者的联合检测对胰腺癌的诊断具有一定意义,同时也可对胰腺癌的侵袭转移提供一项参考依据. Objective To investigate the expressions phosphatidylinositol protein polysaccharide-1 (glypican-1,GPC-1) and chemokine receptor CXCR7 in pancreatic carcinoma and their clinical significance.Methods The expression of GPC-1 (57.69%) and CXCR7(51.92%) was detected by immunohistochemical method in 52 cases of pancreatic cancer tissues and 30 cases of normal pancreatic tissues.All cases were followed up by phone calls.Results The positive expression of GPC-1 and CXCR7 in pancreatic carcinoma was much higher than that of normal pancreatic tissues (x2 =27.293,23.224,P 〈 0.05).The expression of both molecules had positive correlation in pancreatic carcinoma (r =0.758,P 〈 0.05).The expression of GPC-1 and CXCR7 were associated with lymph node metastasis (x2 =14.470,14.034,P 〈0.05).There were no statistical significance between the positive expression of the two indicators and the postoperative survival time of patients (Log Rank =0.086,0.006,P 〉 0.05).Conclusion GPC-1 and CXCR7 are closely related with the occurrence and development of pancreatic cancer,and they are associated with the invasion and metastasis of pancreatic cancer.Combined detection may help the diagnosis of pancreatic cancer.
出处 《国际免疫学杂志》 CAS 2014年第2期157-160,共4页 International Journal of Immunology
  • 相关文献

参考文献15

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CACancer J Clin, 2010,60(5) : 277-300.
  • 2Korc M. Pancreatic cancer-associated stroma production [J] . AmJ Surg,2007,194(4 suppl) : s84-86.
  • 3Filmus J,Capurro M,Rast J. Glypicans[J]. Genome Biol, 2008,9(5) : 224.
  • 4Whipple CA,Young AL, Korc M. A KrasG12D-driven geneticmouse model of pancreatic cancer requires glypican-1 for efficient-proliferation and angiogenesis [J]. Oncogene, 2012 , 31 ( 20 ):2535-2544.
  • 5AikawaT,Whipple CA, Loj.ez ME, et al. Glypican-1 modulatesthe angiogenic and metastatic potential of human and mouse cancerceUs[J]. J Clin Invest, 2008, 118( 1) :89-99.
  • 6Duan L, Hu XQ, Feng DY,et al. GPC-1 may serve as a predictorof perineural invasion and a prognosticator of survival in pancreaticcancer[J]. Asian J Surg,2013 ,36( 1 ) :7-12.
  • 7KleefT J, Ishiwata T, Kumbasar A, et al. The cell-surface heparansulfate proteoglycan glypican-1 regulates growth factor action inpancreatic carcinoma cells and is overexpressed in human pancre-atic cancer[J], J Clin Invest, 1998 , 102(9) : 1662-1673.
  • 8Whipple CA,Lander AD, Korc M. Discovery of a novel moleculethat regulates tumor growth and metastasis [J]. ScientificWorldJournal,2008,8 :1250-1253.
  • 9Horuk R. Chemokine receptors[J]. Cytokine Growth Factor Rev,2001,12 (4): 313-335.
  • 10Balkwill F. Chemokine biology in cancer[J]. Semin Immunol.2003, 159(1) : 49-55.

二级参考文献10

  • 1Zlotnik A. Chemokines and cancer[ J]. Int J Cancer,2006,119 (9) :2026 - 2029.
  • 2Balkwill F, Charles KA, Mantovani A. Smoldering and polarized in- flammation in the initiation and promotion of malignant disease [J]. Cancer Ce11,2005,7(3) :211 -217.
  • 3Bums JM,Summers BC,Wang Y,et al. A novel chemokine receptor for SDF - 1 and I - TAC involved in cell survival, cell adhesion, and tumor development[ J ]. J Exp Med, 2006,203 (9) : 2201 - 2213.
  • 4Meijer J,Ogink J, Roos E. Effect of the chemokine receptor CX- CR7 on proliferation of carcinoma cells in vitro and in vivo[ J]. Br J Cancer,2008,99 ( 9 ) : 1493 - 1501.
  • 5Miao Z,Luker KE,Summers BC, et al. CXCR7 ( RDC1 ) promotes breast and lung tumor growth in vivo and is expressed on tumor - associated vasculature [ J]. Proc Natl Acad Sci USA, 2007,104 (40) :15735 - 15740.
  • 6Goldmann T, D~mann D, Radtke J, et al. CXCR7 transcription in human non - small cell lung cancer and tumor - free lung tissues ; possible regulation upon chemotherapy[ J]. Virchows Arch ,2008, 452 ( 3 ) : 347 - 348.
  • 7Schutyser E,Su Y,Yu Y,et al. Hypoxia enhances CXCR4 expres- sion in human microvascular endothelial ceils and human melanoma ceils[ J]. Eur Cytokine Netw,2007,18 (2) :59 - 70.
  • 8Madden SL, Cook BP, Nacht M, et al. Vascular gene expression in nonneoplastic and malignant brain [ J ]. Am J Pathol, 2004, 165 (2) :601 -608.
  • 9Wang J,Shiozawa Y,Wang J,et al. The role of CXCRT/RDC1 as a chemokine receptor for CXCL12/SDF - 1 in prostate cancer [J]. J Biol Chem,2008,283(7) :4283 -4294.
  • 10曹霞,冯娟,耿嘉蔚,马骏,陈亮,郭强.CXCR7在大肠癌及腺瘤中的表达及其意义[J].中华消化内镜杂志,2009,26(12):651-653. 被引量:3

共引文献2

同被引文献44

  • 1曹峻岭.蛋白聚糖与软骨结构、功能及骨关节病的关系[J].西安交通大学学报(医学版),2012,33(2):131-136. 被引量:15
  • 2刘晶晶,陈樱花,陈小伟,郭剑锋,陈星星,廖敏,张亦农,李和.链脲佐菌素敏感的胰岛细胞表达亨廷顿蛋白相关蛋白1[J].解剖学报,2006,37(3):299-302. 被引量:4
  • 3Pinto S, Marttnez-Romero A, O'Connor JE, et al. Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation [J]. BMC Cancer, 2014, 14:118.
  • 4Richmond A, Yang J, Su Y. The good and the bad of chemokines/ chemokine receptors in melanoma[J].Pigment Cell Melanoma Res, 2009, 22(2): 175-186.
  • 5Longo-Imedio MI, Longo N, Trevifio I, et al. Clinical significance of CXCR3 and CXCR4 expression in primary melanoma [J]. Int J Cancer, 2005, 117(5 ): 861-865.
  • 6Monteagudo C, Martin JM, Jorda E, et al. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors [J]. J Clin Pathol, 2007, 60(6): 596-599.
  • 7Lee E, Han J, Kim K, et al. CXCR7 mediates SDFl-induced melanocyte migration [J]. Pigment Cell Melanoma Res, 2013, 26 ( 1 ): 58-66.
  • 8Sun X, Cheng G, Hao M, et al. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression [J]. Cancer Metastasis Rev, 2010, 29 (4): 709-722.
  • 9Salazar N, Mufioz D, Kallifatidis G, et al. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation[J]. Mol Cancer, 2014, 13: 198.
  • 10Wang J, Shiozawa Y, Wang J, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-I in prostate cancer [J]. J Biol Chem, 2008, 283 (7):4283-4294.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部